Amgen Korea, “We will focus on successful launches of products returned”

Published: 2016-06-07 13:57:48

Updated: 2016-06-07 13:57:48

Amgen Korea announced plans to focus on the domestic settlement of 3 products acquired from GSK.

The company shared future goals and plans to enter the Korean market on February 2016.

“Since the foundation in Korea last year, Amgen has focused on formation of the internal organization, and completed strategy making regarding regulations on substances in pipelines, such as Repatha and romosozu...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.